Obesity Trial, Recruiting NCT06729203 Sponsor: Cairo University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06729203
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who carry excess weight around their midsection (central obesity)
  • Women between 25 and 40 years of age
  • Women with a Body Mass Index (BMI) between 30 and 35 (a measure of body weight relative to height)
  • Women with a waist measurement greater than 88 cm, which indicates excess fat around the abdomen
  • Women who have been diagnosed with insulin resistance, meaning the body does not respond well to insulin (confirmed by a specific blood test result called HOMA-IR above 2.9)
  • Women who do little physical activity — specifically, less than 150 minutes of moderate exercise per week
  • Women who are willing to give formal consent and follow the study's procedures throughout the trial

Who may not be able to join:

  • Women diagnosed with diabetes, based on a blood test result (HbA1c) above 6.5%
  • Women with a history of metabolic conditions such as type 1 diabetes or thyroid disorders
  • Women with a BMI below 30
  • Women who have been diagnosed with heart disease, liver disease, or kidney disease
  • Women who currently take oral contraceptive pills (the pill)
  • Women who have had gestational diabetes (diabetes during pregnancy)
  • Women who are currently pregnant or breastfeeding
  • Women who have used weight-loss medications or supplements in the past six months
  • Women who have previously had surgery for weight loss or body shaping
  • Women with conditions that make ultrasound therapy unsuitable — for example, metal implants in the abdomen or active skin infections in that area
  • Women who have taken part in another clinical trial within the last three months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00201096841660

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 February 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

HOMA ir

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov